Skip to main content

Erdafitinib

Placeholder slot
 (ER-duh-FIH-tih-nib)

This page contains brief information about erdafitinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Balversa
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Erdafitinib is approved to treat:

This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, a confirmatory trial(s) must show that erdafitinib provides a clinical benefit in these patients.

Erdafitinib is also being studied in the treatment of other types of cancer.

More About Erdafitinib

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Drug Erdafitinib Benefits Some Patients with Advanced Bladder Cancer

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Erdafitinib - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: